昌吉治疗重度宫颈糜烂医院(无痛人流昌吉哪家医院安全) (今日更新中)

CANBERRA, May 10 (Xinhua) -- Technology may have a harmful effect on children's development and creativity, Australia's report found on Tuesday.The Pilot Pen Australia Creativity Report found that children could be depending too much on technology such as computers.Written by psychologist Kimberley O'Brien, the report suggested that students are becoming scared of handwritten tasks as there is no spelling or grammar check tool to pick up their mistakes as they go along."Children who develop this kind of dependency on computer software are less likely to write using a pen and paper given that they will feel a vulnerability to failure," the report said.It said using software that immediately tells children to correct errors like spelling and grammar could disrupts their thought patterns and stunts their ideas, and children who hand write are able to produce almost twice as many ideas as those using computer technology to write a creative story.The report studied 300 Year five and six children, and found handwritten essays were completed significantly faster and contained a higher standard of sentence structure, grammar, punctuation, cohesion, ideas development and organization than those completed using keyboards.A further study found students in Years two, four and six produced up to twice as many ideas writing on pen and paper as those on computers.O'Brien said the results were due to computers putting extra pressure on writers to edit as they go rather than get their ideas down first and edit minor mistakes later.O'Brien said children were most likely to develop their handwriting skills between the ages of eight and 10, and she urged all teachers and parents to ensure their children met community standards for legible handwriting.However, she said that computers are a good support tool, and they should not replace handwriting entirely.

BEIJING, Jan. 31 (Xinhua) -- China's Ministry of Finance (MOF) said Monday it had allocated 28.23 billion yuan (4.27 billion U.S. dollars) to assure retired enterprise employees receive their pensions before the arrival of the Spring Festival.The State Council, or the Cabinet, decided at an executive meeting last December to raise the retired enterprise employees' pension about 10 percent from 2010 levels, or about 140 yuan per person per month in 2011.The MOF also said local governments had issued 10.24 billion yuan of festival subsidies to 85.97 million people.The Spring Festival, the Chinese lunar New Year is a time for family reunions in China. It falls on Feb. 3 this year.

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

BEIJING, March 11(Xinhuanet)-- People with more fat around their waist, often known as “apple shape”, may not have a greater risk of heart attack than those with fatter bottoms and hips, according to a new study published in Lancet as quotted by media reports Friday.This study funded by the Medical Research Council and British Heart Foundation, reviewed 220,000 individual records from 17 countries and monitored the occurrence of heart attacks or strokes based on body mass index (BMI) versus waist-hip circumference. It found that people with "apple-shaped" obesity were at a higher risk of having heart risks compared to those with general obesity as assessed by their BMI.  This contradicts previous claims that "apple shaped" bodies were three times more likely to suffer heart attacks than those with more generally distributed fat.But experts warn obesity is still bad for the heart, no matter where the fat is, and they argue there is confusion about the best way to measure it. "Regardless of how you measure it, being obese is bad for your heart. This study suggests that measuring your waist is no better than calculating your BMI but it's not time to throw away the tape measure just yet, “Dr Mike Knapton, associate medical director at the British Heart Foundation said."We tend to underestimate our body shape and size, so measuring our waist or checking our BMI are both quick and easy ways we can check our health at home."Besides, he also listed some other heart risk factors that we need to think about too, such as blood pressure, cholesterol, diabetes and smoking.

BEIJING, March 15 (Xinhuanet) --After one-year effort of developing, Microsoft is going to release its newest web browser Internet Explorer 9 at 9:00 p.m. Pacific time on Monday, according to media reports.The IE 9 will be the first major Web browser to include a do-not-track tool that helps people keep their online habits from being monitored, which makes Google Inc. and Apple Inc. the only big providers of browsers that haven't yet declared their support for a do-no-track system in their products.IE 9 can work on computers running Windows Vista and Windows 7 operating systems, but not compatible with Windows XP.This final release-to-Web version of IE 9 represents the ninth release since the first platform preview of the browser appeared at the MIX 10 Web developer event, said Ryan Gavin, the senior director of Internet Explorer business and marketing. Gavin pointed out that the browser has already made its mark in Microsoft's download history."We're seeing now upwards of two percent share already on Windows 7 for IE 9, even in beta stage. It was the fastest adopted beta ever in Microsoft's history," he said.IE 9 is being launched as part of the South by Southwest event currently taking place in Austin, Texas.

来源：资阳报